Biotech

All Articles

AZ licenses disposed of uncommon disease drug to Monopar Therapeutics

.Monopar Therapeutics is bouncing back a medicine from the scrap heap of AstraZeneca's rare conditio...

Arcus' brand new HIF-2a records in kidney cancer mention possible edge over Merck's Welireg, experts claim

.With brand-new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of experts wor...

Roche bets up to $1B to increase Dyno gene therapy shipment pact

.After creating a gene treatment alliance with Dyno Therapies in 2020, Roche is back for more.In a b...

Lundbeck slashes market value of $250M Abide purchase after pain trouble

.Lundbeck is reducing guide worth of its $250 million Abide Rehabs acquistion in reaction to stage 1...

Real- Planet Data Complies With Scientific Trial Layout: Improving Procedures and also Website Collection

.The integration of real-world information (RWD) right into method feasibility and also internet sit...

Where are they today? Overtaking previous Tough 15 honorees

.At this year's Brutal Biotech Summit in Boston, we overtook forerunners in the biotech field who ha...

Merck snaps up preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is setting down $30 million in advance to buy Yale spinout Modifi Biosciences, a dea...

Radiopharma Alpha-9 raises $175M series C to cash medical push

.Alpha-9 Oncology has actually raised a $175 million series C cycle to stake its clinical-stage radi...

Ocuphire to improve right into genetics treatment biotech via Piece buyout

.Eye medication producer Ocuphire Pharma is actually getting gene treatment developer Piece Genetic ...

Roche culls hack prospect, rotates KRAS system in Q3 update

.Roche's persistent coughing course has actually faltered to a halt. The drugmaker, which axed the p...